Inactive

The Centers for Disease Control and Prevention (CDC) Bacterial Meningitis Laboratory, intends to negotiate a sole source firm-fixed price purchase order contract with Illumina Inc. under authority of ... The Centers for Disease Control and Prevention (CDC) Bacterial Meningitis Laboratory, intends to negotiate a sole source firm-fixed price purchase order contract with Illumina Inc. under authority of Federal Acquisition Regulations Subpart 6.302-1, Other Than Full and Open Competition procedures and FAR Part 13, Simplified Acquisition Procedures for the acquisition of an Illumina Miseq system required as a part of sequencing procedures. This instrument will aid in detection and characterization of bacterial meningitis pathogens from Isolates and clinical specimens submitted to the Bacterial Meningitis Laboratory at CDC (Roybal campus). This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) calendar days of the issuance of this notice will be considered by the Government. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to Brandon Haas, Contract Specialist (CTR, Competitive Range Solutions), at pyx7@cdc.gov by 13:00EST, 17 May 2022.